Marmotti Antonio, de Girolamo Laura, Bonasia Davide Edoardo, Bruzzone Matteo, Mattia Silvia, Rossi Roberto, Montaruli Angela, Dettoni Federico, Castoldi Filippo, Peretti Giuseppe
Department of Orthopaedics and Traumatology, University of Torino, Torino, Italy,
Int Orthop. 2014 Sep;38(9):1787-801. doi: 10.1007/s00264-014-2445-4. Epub 2014 Jul 9.
Stem cells have huge applications in the field of tissue engineering and regenerative medicine. Their use is currently not restricted to the life-threatening diseases but also extended to disorders involving the structural tissues, which may not jeopardize the patients' life, but certainly influence their quality of life. In fact, a particularly popular line of research is represented by the regeneration of bone and cartilage tissues to treat various orthopaedic disorders. Most of these pioneering research lines that aim to create new treatments for diseases that currently have limited therapies are still in the bench of the researchers. However, in recent years, several clinical trials have been started with satisfactory and encouraging results. This article aims to review the concept of stem cells and their characterization in terms of site of residence, differentiation potential and therapeutic prospective. In fact, while only the bone marrow was initially considered as a "reservoir" of this cell population, later, adipose tissue and muscle tissue have provided a considerable amount of cells available for multiple differentiation. In reality, recently, the so-called "stem cell niche" was identified as the perivascular space, recognizing these cells as almost ubiquitous. In the field of bone and joint diseases, their potential to differentiate into multiple cell lines makes their application ideally immediate through three main modalities: (1) cells selected by withdrawal from bone marrow, subsequent culture in the laboratory, and ultimately transplant at the site of injury; (2) bone marrow aspirate, concentrated and directly implanted into the injury site; (3) systemic mobilization of stem cells and other bone marrow precursors by the use of growth factors. The use of this cell population in joint and bone disease will be addressed and discussed, analysing both the clinical outcomes but also the basic research background, which has justified their use for the treatment of bone, cartilage and meniscus tissues.
干细胞在组织工程和再生医学领域有着广泛的应用。目前,它们的用途不仅局限于危及生命的疾病,还扩展到涉及结构组织的疾病,这些疾病可能不会危及患者生命,但肯定会影响他们的生活质量。事实上,一个特别热门的研究方向是以骨和软骨组织的再生来治疗各种骨科疾病。大多数旨在为目前治疗方法有限的疾病创造新疗法的开创性研究仍处于研究人员的实验台上。然而,近年来,已经开展了几项临床试验,取得了令人满意和鼓舞人心的结果。本文旨在回顾干细胞的概念及其在驻留部位、分化潜能和治疗前景方面的特征。事实上,最初只有骨髓被认为是这种细胞群体的“储存库”,后来,脂肪组织和肌肉组织提供了大量可用于多种分化的细胞。实际上,最近所谓的“干细胞生态位”被确定为血管周围空间,认识到这些细胞几乎无处不在。在骨和关节疾病领域,它们分化为多种细胞系的潜能使其通过三种主要方式立即得到理想应用:(1)从骨髓中提取细胞,随后在实验室培养,最终移植到损伤部位;(2)浓缩骨髓抽吸物并直接植入损伤部位;(3)通过使用生长因子对干细胞和其他骨髓前体细胞进行全身动员。本文将探讨和讨论这种细胞群体在关节和骨疾病中的应用,分析临床结果以及基础研究背景,这些背景证明了它们可用于治疗骨、软骨和半月板组织。